Topos Bio:

The hardest problems are the ones worth solving.

Topos Bio is driving a new frontier in drug discovery by targeting intrinsically disordered proteins (IDPs), a vast, overlooked class that focus on diseases like cancer, neurodegeneration, and metabolic dysfunction. The IDPs’ disordered nature has kept them out of reach, until now.

Our role was to convey the transformative potential of Topos Bio’s work: where advanced computation meets biological complexity, and a new class of medicine begins.